Live
CellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMFierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375MBioPharma DiveLilly buys non-opioid pain drugmaker 4EBioPharma DiveExpress Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmaciesBioPharma DiveFDA staff scrutinizes evidence supporting Moderna’s flu vaccineEndpoints NewsEdgewise to advance heart drug into Phase 3 following mid-stage data updateFierceBiotechEdgewise data power rival to BMS and Cytokinetics toward phase 3FierceBiotechiRhythm hit by cyberattack that compromised patient data, says operations unaffectedFierceBiotechMerck inks $510M biobucks data generation partnership with ProtillionEndpoints NewsHow to launch a telehealth business in one dayEndpoints NewsLilly buys another pain biotech; FDA sets decision for once-weekly PrEP pillPharmaVoiceCorvus CEO thinks his next blockbuster is an ITK inhibitor
This story is not available in the archive.